Category Technical Cooperation/ Technology Transfer

BRICS Ministers Join Forces For Access To Medicines

At a side event to the opening of the 2014 World Health Assembly, strong statements were made by BRICS (Brazil, Russia, India, China and South Africa) country ministers and representatives to assume leadership and cooperate to tackle the issue of inaccessibility to affordable medicines in theirs and developing countries.

Independent Review Of WIPO Development Up For Debate

The World Intellectual Property Organization Committee on Development and Intellectual Property opened this week with a loaded agenda and some politically-charged issues. One of them is an independent assessment of the mandated mainstreaming of a development dimension into the activities of the UN organisation.

Rise In Non-Communicable Diseases In Africa Needs To Be Addressed, Speakers Say

The International Organisation of la Francophonie in collaboration with French pharmaceutical umbrella organisation "les Entreprises du médicaments," organised a roundtable on non-communicable diseases on the eve of the annual World Health Assembly.
Several health ministers as well as various stakeholders were invited to discuss "the fight against non-communicable diseases: a shared responsibility" on 18 May.

New Initiative To Address Lack Of Paediatric-Specific HIV Treatments

As the World Health Assembly, a new partnership has been launched by three major public health actors in the field of HIV treatment. The initiative is meant to find improved treatments for children suffering from HIV/AIDs. Although all actors agree that significant progress has been made on adult treatments, children-specific medicines are still lacking.

WHO Report Compares Prices, IP Status Of HIV Treatment In Middle-Income Countries

A new report from the World Health Organization concludes that prices of HIV treatments vary greatly between middle-income countries (MICs), often depending on patent landscape, licensing agreements, whether drugs were sourced from originator companies, and regulatory approval. For third-line treatments, the price of drugs remains a challenge for all, with newer products more likely to be patented in key countries of production.

No Industrial Design Treaty At WIPO In 2014; Technical Assistance Still In The Way

A World Intellectual Property Organization Extraordinary General Assembly was convened this week to confirm the re-election of Francis Gurry as director general, but also to decide on convening a treaty negotiation this year to finish a procedural treaty on industrial designs. No consensus was found on the design treaty, leaving the decision to be deferred to the General Assembly in September.